Industry / China
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Chinese Firm To Provide Antibiotic APIs
January 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Two state-run Indonesian pharmaceutical companies have contracted a Chinese active pharmaceutical ingredient (API) supplier to provide them with bulk antibiotics. By getting a firm commitment from CSPC, which is based in Hubei province in central China, Kimia Farma and Indofarm hope to provide a continuous and affordable supply of drugs to the Indonesian market. BMI believes the partnership will succeed as CSPC is one of the world's leading producers of both penicillins and cephalosporins, and therefore unlikely to not fulfil its production obligations.